Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Gene Literature (177) GO Terms (26) Nucleotides (48) Proteins (31) Interactants (65) Wiki
XB--962200

Papers associated with cnr1

Search for cnr1 morpholinos using Textpresso

Limit to papers also referencing gene:
1 paper(s) referencing morpholinos

Results 1 - 32 of 32 results

Page(s): 1

Sort Newest To Oldest Sort Oldest To Newest

Investigation of non-CB1, non-CB2 WIN55212-2-sensitive G-protein-coupled receptors in the brains of mammals, birds, and amphibians., Breivogel CS, McPartland JM, Parekh B., J Recept Signal Transduct Res. August 1, 2018; 38 (4): 316-326.


The Peptide PnPP-19, a Spider Toxin Derivative, Activates μ-Opioid Receptors and Modulates Calcium Channels., Freitas ACN, Peigneur S, Macedo FHP, Menezes-Filho JE, Millns P, Medeiros LF, Arruda MA, Cruz J, Holliday ND, Tytgat J, Hathway G, de Lima ME., Toxins (Basel). January 1, 2018; 10 (1):             


The Cannabinoid Receptor Interacting Proteins 1 of zebrafish are not required for morphological development, viability or fertility., Fin L, Bergamin G, Steiner RA, Hughes SM., Sci Rep. January 1, 2017; 7 (1): 4858.        


An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction., Hutch CR, Hillard CJ, Jia C, Hegg CC., Neuroscience. August 6, 2015; 300 539-53.


cnrip1 is a regulator of eye and neural development in Xenopus laevis., Zheng X, Suzuki T, Takahashi C, Nishida E, Kusakabe M., Genes Cells. April 1, 2015; 20 (4): 324-39.                          


The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors., Baur R, Gertsch J, Sigel E., Br J Pharmacol. April 1, 2012; 165 (8): 2479-84.


Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism., Xiong W, Koo BN, Morton R, Zhang L., Neuroscience. June 16, 2011; 184 28-37.


Endocannabinoid modulation in the olfactory epithelium., Breunig E, Czesnik D, Piscitelli F, Di Marzo V, Manzini I, Schild D., Results Probl Cell Differ. January 1, 2010; 52 139-45.


About a snail, a toad, and rodents: animal models for adaptation research., Roubos EW, Jenks BG, Xu L, Kuribara M, Scheenen WJ, Kozicz T., Front Endocrinol (Lausanne). January 1, 2010; 1 4.      


mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis., Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, Kanaide M, Taniyama K, Sumikawa K, Uezono Y., J Pharmacol Sci. November 1, 2008; 108 (3): 308-19.


Endocannabinoids affect the reproductive functions in teleosts and amphibians., Cottone E, Guastalla A, Mackie K, Franzoni MF., Mol Cell Endocrinol. April 16, 2008; 286 (1-2 Suppl 1): S41-5.


The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes., Kracke GR, Stoneking SP, Ball JM, Tilghman BM, Washington CC, Hotaling KA, Johnson JO, Tobias JD., Naunyn Schmiedebergs Arch Pharmacol. December 1, 2007; 376 (4): 285-93.


Cannabinoid action in the olfactory epithelium., Czesnik D, Schild D, Kuduz J, Manzini I., Proc Natl Acad Sci U S A. February 20, 2007; 104 (8): 2967-72.        


Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics., Migliarini B, Beatrice M, Marucci G, Gabriella M, Ghelfi F, Francesca G, Carnevali O, Oliana C., FEBS Lett. April 3, 2006; 580 (8): 1941-5.


Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors., Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L., Mol Pharmacol. March 1, 2006; 69 (3): 991-7.


Neuroanatomical distribution of cannabinoid receptor gene expression in the brain of the rough-skinned newt, Taricha granulosa., Hollis DM, Coddington EJ, Moore FL., Brain Behav Evol. January 1, 2006; 67 (3): 135-49.


Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation., McAllister SD, Hurst DP, Barnett-Norris J, Lynch D, Reggio PH, Abood ME., J Biol Chem. November 12, 2004; 279 (46): 48024-37.


Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist., Luk T, Jin W, Zvonok A, Lu D, Lin XZ, Chavkin C, Makriyannis A, Mackie K., Br J Pharmacol. June 1, 2004; 142 (3): 495-500.


Xenopus laevis CB1 cannabinoid receptor: molecular cloning and mRNA distribution in the central nervous system., Cottone E, Salio C, Conrath M, Franzoni MF., J Comp Neurol. September 29, 2003; 464 (4): 487-96.        


The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes., Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, Morales M., J Pharmacol Exp Ther. September 1, 2003; 306 (3): 1003-10.


Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes., Oz M, Zhang L, Morales M., Synapse. December 1, 2002; 46 (3): 150-6.


CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers., Salio C, Cottone E, Conrath M, Franzoni MF., J Chem Neuroanat. September 1, 2002; 24 (3): 153-62.


Relationships between CB1 cannabinoid receptors and pituitary endocrine cells in Xenopus laevis: an immunohistochemical study., Cesa R, Guastalla A, Cottone E, Mackie K, Beltramo M, Franzoni MF., Gen Comp Endocrinol. January 1, 2002; 125 (1): 17-24.    


Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis., Cesa R, Mackie K, Beltramo M, Franzoni MF., Cell Tissue Res. December 1, 2001; 306 (3): 391-8.


In-vitro and in-vivo action of cannabinoids., Akinshola BE, Chakrabarti A, Onaivi ES., Neurochem Res. October 1, 1999; 24 (10): 1233-40.


Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP., Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1999; 360 (3): 242-8.


Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors., Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V., Biochem Biophys Res Commun. August 19, 1999; 262 (1): 275-84.


Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide., Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED., Nature. July 29, 1999; 400 (6743): 452-7.


Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system., Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME., Eur J Pharmacol. July 14, 1999; 377 (1): 117-25.


Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization., Jin W, Brown S, Roche JP, Hsieh C, Celver JP, Kovoor A, Chavkin C, Mackie K., J Neurosci. May 15, 1999; 19 (10): 3773-80.


Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels., Ho BY, Uezono Y, Takada S, Takase I, Izumi F., Recept Channels. January 1, 1999; 6 (5): 363-74.


Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons., Twitchell W, Brown S, Mackie K., J Neurophysiol. July 1, 1997; 78 (1): 43-50.

Page(s): 1